Leuprolide
Records for this ingredient, by country (identity only).
ATC L02AE02 · 4 markets · 39 records
CA 14 records · 10 shown of 10
- 45 mgpowder · extended-releaseELIGARDLupron Depot
- 30 mgpowder · extended-releaseELIGARDLupron Depot
- 22.5 mgpowder · extended-releaseELIGARDLupron Depot
- 7.5 mgpowder · extended-releaseELIGARDLupron Depot
- 42 mg per mL / per unit basis not statedliquid · extended-releaseCAMCEVI
- 22.5 mg per mL / per unit basis not statedliquid · extended-releaseZEULIDE DEPOT
- 21 mg per mL / per unit basis not statedliquid · extended-releaseCAMCEVI
- 3.75 mg per mL / per unit basis not statedliquid · extended-releaseZEULIDE DEPOT
- 11.25 mgpowder · extended-releaseLupron Depot
- 3.75 mgpowder · extended-releaseLupron Depot
US 12 records · 6 shown of 6
- 45 mg/0.375 mLinjection · extended-releaseELIGARDFensolvi、Vabrinty
- 30 mg/0.5 mLinjection · extended-releaseELIGARDVabrinty
- 22.5 mg/0.375 mLinjection · extended-releaseELIGARDVabrinty
- 7.5 mg/0.25 mLinjection · extended-releaseELIGARDVabrinty
- 42 mg/370 mginjectionCAMCEVI
- 1 mg/0.2 mLinjectionManufacturer: Endo USA, Inc.
TW 2 records · 2 shown of 2
- 42 mg per mL / per unit basis not statedinjectionCAMCEVI (Leuprolide) injectable emulsion, 42 mg康紓維(柳菩林)42毫克注射乳劑
- 5 mg per mL / per unit basis not statedinjectionLupro Injection 5mg/ml恩必來注射液 5 毫克/毫升
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.